• Insights

    Beyond the PE Ratio: Why Investors Must Look Deeper as Valuations Stretch

    Grady Wulff
    December 10, 2025
    Read Article
  • Insights

    Cybersecurity: The defensive backbone of AI spending in 2026

    Grady Wulff
    December 4, 2025
    Read Article
  • Insights

    Positioning Your Portfolio for a Market Correction: And Spotting the Buying Opportunities

    Grady Wulff
    November 26, 2025
    Read Article

Latest DBTV Videos

Weekly Wrap 19 June

Bell Direct
June 19, 2026

Weekly Wrap 12 June

Bell Direct
June 12, 2026
Market Wraps

Weekly Wrap 24 April

Bell Direct
April 24, 2026
Market Wraps

Weekly Wrap 17 April

Bell Direct
April 17, 2026
Interview Series

From the helm: Centaurus Metals (ASX:CTM), CEO & MD, Darren Gordon

Bell Direct
April 2, 2026
Interview Series

From the helm: Oneview Healthcare (ASX:ONE), CEO, James Fitter

Bell Direct
April 2, 2026
Interview Series

From the helm: Titomic Ltd, CFO, Geoff Hollis

Bell Direct
April 1, 2026
Interview Series

From the helm: Artrya Limited (ASX:AYA): John Konstantopoulos, CEO & Co-Founder

Bell Direct
April 1, 2026
Interview Series

From the helm: Bell Financial Group (ASX:BFG): Arnie Selvarajah, Group Co-CEO

Bell Direct
April 1, 2026
Market Wraps

Navigating geopolitical turbulence:The strategic case for defence technology

Bell Direct
March 31, 2026
Market Wraps

Weekly Wrap 27 March

Bell Direct
March 27, 2026
Interview Series

From the helm: Saluda Medical (ASX:SLD), President & CEO, Barry Regan

Bell Direct
March 20, 2026
Interview Series

From the helm: Clarity Pharma (ASX:CU6), Chair, Alan Taylor & Senior Bell Potter Analyst John Hester

Bell Direct
March 20, 2026
Interview Series

From the helm: Summerset Group Holdings (ASX:SNZ), CFO, Margaret Warrington.

Bell Direct
March 20, 2026
Interview Series

From the helm: Amplia (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.

Bell Direct
March 20, 2026
Interview Series

From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.

Bell Direct
March 20, 2026
Interview Series

From the helm: Neuren Pharmaceuticals (ASX:NEU), CEO, Jon Pilcher.

Bell Direct
March 20, 2026
Interview Series

From the helm: Mesoblast (ASX:MSB), Director, Silviu Itescu

Bell Direct
March 20, 2026
SEE ALL VIDEOS

Latest Articles

Insights

Beyond the PE Ratio: Why Investors Must Look Deeper as Valuations Stretch

Grady Wulff
December 10, 2025
Insights

Cybersecurity: The defensive backbone of AI spending in 2026

Grady Wulff
December 4, 2025
Insights

Positioning Your Portfolio for a Market Correction: And Spotting the Buying Opportunities

Grady Wulff
November 26, 2025
Insights

CY25: gold glitters, AI accelerates and defence dominates. Are markets set for one more Santa rally?

Grady Wulff
November 20, 2025
Insights

Increased defence spend fuels new tailwind for critical metals

Grady Wulff
October 15, 2025
Insights

August 2025 Reporting Season Outlook

Grady Wulff
July 30, 2025
SEE ALL ARTICLES

If you are ready to get started

GET IN TOUCH